Decline of dopamine: effects of age and acute neuroleptic challenge.
Lieberman
J A
JA
Mailman
R
R
D000375:Aging / Q000378:metabolism*; D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D001921:Brain / Q000000981:diagnostic imaging / Q000187:drug effects / Q000378:metabolism*; D001923:Brain Chemistry / Q000187:drug effects; D003847:Deoxyglucose; D005947:Glucose / Q000378:metabolism; D006801:Humans; D008253:Macaca mulatta; D009483:Neuropsychological Tests; D051381:Rats; D017448:Receptors, Dopamine D2 / Q000032:analysis*; D012559:Schizophrenia / Q000188:drug therapy / Q000378:metabolism; D014055:Tomography, Emission-Computed
D014150:Antipsychotic Agents; D017448:Receptors, Dopamine D2; D003847:Deoxyglucose; D005947:Glucose